Kanagawa, Japan

Koji Ono

This inventor holds 112 USPTO granted patents and 4 published patent applications and 5 EPO patents, primarily in Heterocyclic Compounds (CPC class H01L29-4908). Top assignees: Semiconductor Energy Laboratory Co., Ltd., Takeda Pharmaceutical Company Limited, Ebara Corporation. Active years: 1998-2025.

USPTO Granted Patents = 112 

% Patents Active = 42.0

 

Average Co-Inventor Count = 3.5

ph-index = 24

Forward Citations = 1,921(Granted Patents)

Forward Citations (Not Self Cited) = 1,654(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Kanagawa-ken, JP (2003 - 2012)
  • Sagamihara, JP (2013 - 2014)
  • Tsukuba, JP (2015)
  • Atsugi, JP (2006 - 2017)
  • Tochigi, JP (2007 - 2017)
  • Tokyo, JP (2004 - 2021)
  • Fujisawa, JP (1998 - 2022)
  • Kanagawa, JP (2002 - 2024)

Company Filing History:


Years Active: 1998-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
CDK12 Inhibitors
Spinal Muscular Atrophy
Fused Heterocyclic Compound
Electroluminescence Display
Semiconductor Device
Light-Emitting Device
Heteroaryl Compounds
Metal Wiring
Communication System
Pyrrole Compounds
Manufacturing Method
112 patents (USPTO):Explore Patents

Title: Koji Ono: A Visionary Inventor Shaping the Future of Innovation

Introduction:

Koji Ono is a visionary inventor whose passion for innovation and relentless pursuit of excellence have solidified his reputation as a trailblazer in the field. His work has not only led to groundbreaking discoveries but has also inspired the next generation of innovators to push the boundaries of what is thought possible.

Latest Patents:

Koji Ono's latest patents showcase his commitment to advancing life-saving technologies. One of his notable inventions includes "Substituted pyrazolo[1,5-a]pyrazines for spinal muscular atrophy," a prophylactic or therapeutic agent that holds promise in the treatment of spinal muscular atrophy. Additionally, his patent on a "Heterocyclic compound" demonstrates his dedication to developing novel compounds with potential inhibitory action for diseases like cancer.

Career Highlights:

With an impressive 111 patents to his name, Koji Ono has made significant contributions to the field of innovation. He has worked with esteemed companies such as Semiconductor Energy Laboratory Co., Ltd. and Ebara Corporation, where his inventive spirit has flourished. Through his work, he has propelled advancements in various industries, leaving a lasting impact on the world of technology.

Collaborations:

Koji Ono's collaborations with talented individuals such as Hideomi Suzawa and Shunpei Yamazaki have been instrumental in bringing his innovative ideas to life. Together, they have shared a common goal of pushing the boundaries of scientific discovery and creating solutions that address pressing societal needs. Their collaborative efforts have laid the groundwork for groundbreaking inventions that have the potential to revolutionize the way we approach healthcare and technology.

Conclusion:

In conclusion, Koji Ono's unwavering dedication to innovation and his remarkable portfolio of patents stand as a testament to his visionary mindset. His influence extends far beyond the realm of invention, inspiring others to think creatively and pursue excellence in their respective fields. As a pioneering inventor, Koji Ono continues to shape the future of innovation, leaving a legacy that will undoubtedly inspire generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…